Methods of Improvement Adherence With Therapy in Ulcerative Colitis.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00398593|
Recruitment Status : Unknown
Verified February 2009 by University Hospitals, Leicester.
Recruitment status was: Active, not recruiting
First Posted : November 14, 2006
Last Update Posted : February 16, 2009
Ulcerative Colitis is associated with a significantly increased risk of colorectal cancer. This risk can be reduced through regular medication with 5ASA compounds. Their effectiveness however is limited by poor adherence to the treatment protocols by many patients.
The hypothesis which underlies this proposal is that if the factors responsible for poor compliance can be identified, interventions could be developed which would help to overcome the barriers which exist in individual patients. These interventions would be based on the reasons for non-adherence, specifically tailored to the needs of the individual. As a result such interventions will improve patients' adherence with prescribed 5ASA and therefore reduce the relapses of the disease and a cancer risk.
|Condition or disease||Intervention/treatment||Phase|
|Ulcerative Colitis||Behavioral: Range of electronic pill dispensers with alarms||Phase 3|
Poor adherence to treatment is well recognised and significantly contributes to treatment failures. In ulcerative colitis it may be associated with an increased risk of colorectal cancer. Estimates for non-adherence range from 15% to 93% with an average of around a third of patients failing to adhere to their recommended therapeutic regimen.
The study aims to evaluate a wide-ranging approach to reducing poor adherence, which is based on factors associated with non-adherence and involves the patient in choosing interventions.
The effectiveness of the overall intervention will be assessed through a randomised controlled trial comparing intervention against standard care.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Patient Adherence to Prescribed Therapy in Ulcerative Colitis: an Investigation of Barriers & Methods of Improvement.|
|Study Start Date :||December 2007|
|Actual Primary Completion Date :||April 2008|
|Estimated Study Completion Date :||April 2009|
Behavioral: Range of electronic pill dispensers with alarms
- Levels of patient adherence to therapy will be assessed in two ways: [ Time Frame: 1 year ]
- through pill counts and measurement of salicylate levels in urine samples. [ Time Frame: 1 year ]
- Quantitative data will be collected through feedback from patients. [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00398593
|Principal Investigator:||John F Mayberry, DScMD||University Hospitals, Leicester|